Reports

About NeuroInsights

As the neurotech market authority, NeuroInsights helps investors, executives and governments understand and profit from the rapid growth of drugs, devices and diagnostics for the brain and nervous system. Our products and services include:

• Market and investment reports
• Monthly industry newsletter
• Investing and partnering conferences
• Business and investor advisory services 

NeuroInsights' publications enable you to track market dynamics, develop investment strategies, identify partnering opportunities, and analyze comparables across the across this $155 billion global industry.

Recent News
5.02.13  Neurogaming Conference: Days of Future Past 

5.01.13  This Gaming Conference will Make You Use Your Head

5.01.13  VentureBeat: Neurogaming is a nascent market fueled by brain games and sensors

5.01.13  Orphan Disorders Take Center Stage with Investors

2.01.13  NeuroInsights Interviews Novel Pain Startup in Neurotech Insights

2.01.12 NeuroInsights publishes new report Stem Cell Approaches in Neurology and Psychiatry: 25 Trendsetters for 2013

11.01.12 Neurotech Insights Focuses on New Treatments for Attention Deficit Hyperactivity Disorder

08.01.12 Neurotech Industry 2012 Report Released, 580-Page Analysis of Global Opportunities

5.31.12  Neurotech Revenues Reach $158.6 Billion with 5.6% Growth According to NeuroInsights
Neurotech Insights

5.21.12  Highlights from Neurotech 2012: Investing in Neurotech
Neurotech Insights

5.21.12  Highlights from Neurotech 2012: Trends in Partnering and Licensing
Neurotech Insights

4.25.12 Neurodiagnostics Report 2012: Brain Imaging, Biomarkers and NeuroInformatics Published

3.20.12 Speakers Announced for 7th Annual Neurotech Investing and Partnering Conference in Boston May, 21-22

1.1.12  Neurotech Venture Investment up 17%, Devices Comeback
Neurotech Insights

8.1.11 Effective Alzheimer's Therapies Elusive

5.9.11 NeuroInsights partners with OPN Capital Markets to provide premier services to investors and companies

5.9.11 Neurotechnology Revenues Reach $150 Billion According to NeuroInsights

2.22.11 Helsinki to Host the First European Neurotech Investing and Partnering Summit

2.8.11 Leading Executives and Investors to Speak at Neurotech 2011

2.1.11 Alzheimer's Diagnosis: Are We There Yet?
Neurotech Insights